Theranostics Health Announces CAP Accreditation for its TheraLink® CLIA Laboratory

Theranostics Health announced today that it has been awarded accreditation by the College of American Pathologists (CAP) for its high complexity CLIA laboratory that offers the TheraLink® Assay for Breast Cancer, a comprehensive phospho-proteomic molecular test employing reverse-phase protein array technology to help oncologists make more informed treatment decisions for patients with cancer.